Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China

Abstract

Background The global numbers of confirmed cases and deceased critically ill patients with COVID-19 are increasing. However, the clinical course, and the 60-day mortality and its predictors in critically ill patients have not been fully elucidated. The aim of this study is to identify the clinical course, and 60-day mortality and its predictors in critically ill patients with COVID-19. Methods Critically ill adult patients admitted to intensive care units (ICUs) from 3 hospitals in Wuhan, China, were included. Data on demographic information, preexisting comorbidities, laboratory findings at ICU admission, treatments, clinical outcomes, and results of SARS-CoV-2 RNA tests and of serum SARS-CoV-2 IgM were collected including the duration between symptom onset and negative conversion of SARS-CoV-2 RNA. Results Of 1748 patients with COVID-19, 239 (13.7%) critically ill patients were included. Complications included acute respiratory distress syndrome (ARDS) in 164 (68.6%) patients, coagulopathy in 150 (62.7%) patients, acute cardiac injury in 103 (43.1%) patients, and acute kidney injury (AKI) in 119 (49.8%) patients, which occurred 15.5 days, 17 days, 18.5 days, and 19 days after the symptom onset, respectively. The median duration of the negative conversion of SARS-CoV-2 RNA was 30 (range 6–81) days in 49 critically ill survivors that were identified. A total of 147 (61.5%) patients deceased by 60 days after ICU admission. The median duration between ICU admission and decease was 12 (range 3–36). Cox proportional-hazards regression analysis revealed that age older than 65 years, thrombocytopenia at ICU admission, ARDS, and AKI independently predicted the 60-day mortality. Conclusions Severe complications are common and the 60-day mortality of critically ill patients with COVID-19 is considerably high. The duration of the negative conversion of SARS-CoV-2 RNA and its association with the severity of critically ill patients with COVID-19 should be seriously considered and further studied.

Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series

“…We failed to show any differences in mortality between mechanically ventilated versus non-mechanically ventilated patients [ 3 , 4 , 7 , 8 ] but our retrospective study was significantly underpowered. However, subgroup analysis revealed higher body mass index and rate of nosocomial acquired infections in the COVID-19 mechanically ventilated subgroup of patients versus the non-mechanically ventilated group, which is in accordance with previous reports [ [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] ]. In our study, the incidence of nosocomial acquired infections based on strict clinical criteria was 19.6%, which although an important cofactor did not affect mortality during TCZ therapy.…”

Association of Peripheral Lymphocyte and the Subset Levels With the Progression and Mortality of COVID-19: A Systematic Review and Meta-Analysis

“…The search strategy identified 7,385 records: 6,528 from PubMed, 465 from CNKI, 322 from Wangfan, and 70 from other sources (Figure 1). After excluding duplicated and irrelevant records, 16 studies were included in this meta-analysis with a total of 10,624 COVID-19 cases ( Table 1) (4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). Thirteen studies derived from China, while one study came from the USA, one from Spain and one from India.…”

Impact of a Double Epidemic in Mexico: Non-Communicable Diseases Increase the Case Fatality Rate with Covid-19

“…This combination is one of the most commonly found in adults around the world 27 and can be attributed to the fact that multiple organ failure is associated with increased levels of plasminogen, which produces coronary thrombosis and pulmonary embolism. 30 In general, we found that a greater presence of NCDs increases CFR because it re ects multiorgan dysfunction, severity, and worse prognosis. [31][32] We observed a triple interaction between number of NCDs, age, and sex.…”